Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Routbort

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Cancers|November 13, 2025
Comparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene Rearrangements in Acute LeukemiaChi Young Ok, Guilin Tang, Sanam Loghavi, et al.
Plos One|March 8, 2017
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancerAmir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2016
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)Courtney D DiNardo, Sarah A Bannon, Mark Routbort, et al.
Cancer|November 23, 2017
Physician interpretation of genomic test results and treatment selectionLauren L Brusco, Chetna Wathoo, Kenna R Mills Shaw, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 3, 2020
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1Andrés E Quesada, Guillermo Montalban-Bravo, Rajyalakshmi Luthra, et al.
Oncotarget|September 10, 2019
Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratoryNatalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular SubtypesJonathan M Loree, Allan A L Pereira, Michael Lam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Concordance between tumor tissue and plasma DNA genotyping in the NCI-MATCH trial (EAY131)Mohamed A Gouda, Filip Janku, Ying Yuan, et al.
British Journal of Haematology|June 28, 2019
Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patientsBoyu Hu, Keyur P Patel, Hsiang-Chun Chen, et al.
Human Pathology|June 11, 2015
Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced MelanomaMichael T Tetzlaff, Penvadee Pattanaprichakul, Jennifer Wargo, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Cancers|November 13, 2025
Comparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene Rearrangements in Acute LeukemiaChi Young Ok, Guilin Tang, Sanam Loghavi, et al.
Plos One|March 8, 2017
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancerAmir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2016
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)Courtney D DiNardo, Sarah A Bannon, Mark Routbort, et al.
Cancer|November 23, 2017
Physician interpretation of genomic test results and treatment selectionLauren L Brusco, Chetna Wathoo, Kenna R Mills Shaw, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 3, 2020
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1Andrés E Quesada, Guillermo Montalban-Bravo, Rajyalakshmi Luthra, et al.
Oncotarget|September 10, 2019
Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratoryNatalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular SubtypesJonathan M Loree, Allan A L Pereira, Michael Lam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Concordance between tumor tissue and plasma DNA genotyping in the NCI-MATCH trial (EAY131)Mohamed A Gouda, Filip Janku, Ying Yuan, et al.
British Journal of Haematology|June 28, 2019
Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patientsBoyu Hu, Keyur P Patel, Hsiang-Chun Chen, et al.
Human Pathology|June 11, 2015
Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced MelanomaMichael T Tetzlaff, Penvadee Pattanaprichakul, Jennifer Wargo, et al.
Pageof 18